Evidence map›Paper›PMID 38091015›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2024

Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation.

Weihao Lv, Qianqian Zhang, Yuanming Li, Dan Liu, Xiuquan Wu, Xin He, Yuanyuan Han, Xiaowei Fei, Lei Zhang, Zhou Fei

Open access · hybridAbstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Polyploid cancer cells reveal signatures of chemotherapy resistance.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Weihao Lv *Department of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China.
Qianqian Zhang *Department of Respiratory Medicine, Lanzhou University Second Hospital, Lanzhou, 730070, China.
Yuanming Li *Department of Neurology, Gansu Province Central Hospital, Lanzhou, 730070, China.
Dan LiuDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China.
Xiuquan WuDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China.
Xin HeDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China.
Yuanyuan HanDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China.
Xiaowei FeiDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China. xiaowei_fei@fmmu.edu.cn.
Lei ZhangDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China. zhanglei20230707@163.com.
Zhou FeiDepartment of Neurosurgery, Xijing Hospital, Air Force Medical University, No. 127, Changle West Road, Xincheng District, Xi'an, Shaanxi, 710032, China. feizhou@fmmu.edu.cn.
Air Force Medical University · CNXijing Hospital · CNGansu Provincial Hospital · CNLanzhou University · CN

Funding

Natural Science Foundation of China 81771239
6 · The paper itself

Abstract

objectiveProinflammatory necroptosis is the main pathological mechanism of ischemic stroke. Homer scaffolding protein 1 (Homer1) is a postsynaptic scaffolding protein that exerts anti-inflammatory effects in most central nervous system diseases. However, the relationship between Homer1 and proinflammatory necroptosis in ischemic stroke remains unclear.

aimThis study aimed to investigate the role of Homer1 in ischemia-induced necroptosis.

methodsC57BL/6 mice were used to establish a model of permanent middle cerebral artery occlusion model (pMCAO). Homer1 knockdown mice were generated using adeno-associated virus (AAV) infection to explore the role of Homer1 and its impact on necroptosis in pMCAO. Finally, Homer1 protein was stereotaxically injected into the ischemic cortex of Homer1

resultsHomer1 expression peaked at 8 h in the ischemic penumbral cortex after pMCAO and colocalized with neurons. Homer1 knockdown promoted neuronal death by enhancing necroptotic signaling pathways and aggravating ischemic brain damage in mice. Furthermore, the knockdown of Homer1 enhanced the expression of proinflammatory cytokines. Moreover, injection of Homer1 protein reduced necroptosis-induced brain injury inhibited the expression of proinflammatory factors, and ameliorated the outcomes in the Homer1

conclusionsHomer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation. These data suggested that Homer1 is a novel regulator of neuronal death and neuroinflammation.

Indexed as

Brain IschemiaIschemic StrokeStrokeAnimalsHomer Scaffolding ProteinsInfarction, Middle Cerebral ArteryMiceMice, Inbred C57BLNecroptosisNestinNeuroinflammatory DiseasesNeuronsHomer1 protein, mouseHomer Scaffolding ProteinsNestinHomer1Ischemic strokeNecroptosisNeuroinflammation

Identifiers

PMID38091015
PMCPMC10776472
OpenAlexW4389685823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.